[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

The 2011 Leading Pharmaceutical Companies Strategic Directions

October 2010 | 45 pages | ID: L8CE83A8612EN
Venture Planning Group

US$ 1,480.00 US$ 1,850.00 -20 %

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Global PDF: US$ 3,900.00

For each company, the report provides insightful strategic assessments, including:
  • Major strengths and weaknesses.
  • Business, new product development, and marketing objectives and strategies.
  • Anticipated acquisitions, joint ventures and divestitures.
The companies analyzed in the report:

        -   AstraZeneca
        -   Bristol-Myers Squibb
        -   GlaxoSmithKline
        -   Johnson & Johnson
        -   Merck
        -   Novartis
        -   Pfizer
        -   Roche
        -   Sanofi-Aventis
        -   Wyeth

Contains 45 pages


More Publications